Weakly Supervised LSTM RNNs for Longitudinal Breast Cancer Recurrence Prediction via Unstructured Clinical Narratives
ISEF · 2020 Robotics and Intelligent Machines
Overview
Breast cancer is the most common cancer in women globally, causing an estimated 626,700 deaths in 2018. As the late detection of breast cancer recurrence leads to a 1-1.5% curability rate, my project presents the first attempt to predict breast cancer recurrence, 1 year in advance, by leveraging unstructured clinical narratives in EHR over a patient’s temporal visit sequence. I first develop robust, encoded representations of the unstructured clinical narratives. This is done through text preprocessing in which notes are standardized, noise is eliminated, and semantic meaning is preserved. Next, I train unsupervised word2vec embeddings across a corpus of ~100 million notes from 3 institutions for increased generalization. Finally, robust document-level embeddings are computed as a weighted average of word vectors in the document. Using the document-level embeddings, I train a weakly supervised, many-to-many, stacked stateful LSTM RNN for longitudinal recurrence prediction. The model is validated, trained, and tested on ~154K notes from 940 distinct patients, achieving 0.841 ROC AUC on the hold-out test set. The model’s comprehensive, fully automated analysis of unstructured clinical narratives with limited ground truth labels can also be generalized to other types of cancers and diseases to offer key insights into future clinical events. Unlike previous “black-box” models, my model can be visualized, engendering trust in clinicians to leverage and utilize its personalized predictions as a pivotal part in determining adequate treatment. This allows clinicians to improve patient survival by treating recurrences earlier and even preventing them from occurring in the first place.
Competition history
- ISEF 2020
Resources
Related projects
ISEF · 2025
OncoNote: Enabling the Discovery of a Novel Digital Biomarker for Early Pan-Cancer Survival and Recurrence Prediction via Free-Text Clinical Narratives
ISEF · 2018
Deep, Multimodal Representation Learning for Pan-Cancer Prognosis Prediction
ISEF · 2023
A Novel Breast Cancer Recurrence Risk Predictor Using a Deep Learning Multi-omics Data Integration Framework
ISEF · 2026
OncoTwin: A Multi-Modal, Treatment-Based Digital Twin for Cancer Recurrence Risk Prediction and Biomarker Discovery
Closest projects by meaning, across every fair and year in the corpus.
Source: Regeneron International Science and Engineering Fair